ScoreWhy is Honz Pharmaceutical Co., Ltd. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of -11.91% and Operating profit at -231.89% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
The company has declared negative results for the last 5 consecutive quarters
- NET SALES(HY) At CNY 215.06 MM has Grown at -44.19%
- NET PROFIT(HY) At CNY -78.48 MM has Grown at -1,232.12%
- ROCE(HY) Lowest at -14.74%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of 59.65%, its profits have fallen by -48.2%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Honz Pharmaceutical Co., Ltd. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Honz Pharmaceutical Co., Ltd.
-100.0%
2.28
63.97%
China Shanghai Composite
15.19%
1.01
15.10%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-11.91%
EBIT Growth (5y)
-231.89%
EBIT to Interest (avg)
-2.46
Debt to EBITDA (avg)
31.18
Net Debt to Equity (avg)
0.37
Sales to Capital Employed (avg)
0.33
Tax Ratio
3.46%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0.44%
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.64
EV to EBIT
-22.26
EV to EBITDA
-44.19
EV to Capital Employed
2.20
EV to Sales
6.91
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-9.87%
ROE (Latest)
-14.06%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 143.45 MM
RAW MATERIAL COST(Y)
Fallen by -25.33% (YoY
OPERATING PROFIT(Q)
Highest at CNY -7.7 MM
OPERATING PROFIT MARGIN(Q)
Highest at -7.02 %
PRE-TAX PROFIT(Q)
Highest at CNY -9.95 MM
NET PROFIT(Q)
Highest at CNY -9.69 MM
EPS(Q)
Highest at CNY -0.02
-24What is not working for the Company
NET SALES(HY)
At CNY 215.06 MM has Grown at -44.19%
NET PROFIT(HY)
At CNY -78.48 MM has Grown at -1,232.12%
ROCE(HY)
Lowest at -14.74%
DEBT-EQUITY RATIO
(HY)
Highest at 38.5 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.22%
CASH AND EQV(HY)
Lowest at CNY 206.15 MM
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.07%
Here's what is working for Honz Pharmaceutical Co., Ltd.
Operating Cash Flow
Highest at CNY 143.45 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Operating Profit
Highest at CNY -7.7 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at -7.02 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CNY -9.95 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Pre-Tax Profit
At CNY -9.95 MM has Grown at 79.21%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Net Profit
Highest at CNY -9.69 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
Net Profit
At CNY -9.69 MM has Grown at 79.16%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (CNY MM)
EPS
Highest at CNY -0.02
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (CNY)
Raw Material Cost
Fallen by -25.33% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Honz Pharmaceutical Co., Ltd.
Net Sales
At CNY 215.06 MM has Grown at -44.19%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (CNY MM)
Debt-Equity Ratio
Highest at 38.5 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 1.22% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Cash and Eqv
Lowest at CNY 206.15 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debtors Turnover Ratio
Lowest at 3.07%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
